Did the Randomized Phase III KEYNOTE-181 Study of Pembrolizumab for Esophageal Cancer Yield Negative or Positive Results?. Issue 20 (10th July 2021)

Record Type:
Journal Article
Title:
Did the Randomized Phase III KEYNOTE-181 Study of Pembrolizumab for Esophageal Cancer Yield Negative or Positive Results?. Issue 20 (10th July 2021)
Main Title:
Did the Randomized Phase III KEYNOTE-181 Study of Pembrolizumab for Esophageal Cancer Yield Negative or Positive Results?
Authors:
Minami, Hironobu
Kiyota, Naomi
Omori, Takashi
Abstract:
Is Part Of:
Journal of clinical oncology. Volume 39:Issue 20(2021)
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 20(2021)
Issue Display:
Volume 39, Issue 20 (2021)
Year:
2021
Volume:
39
Issue:
20
Issue Sort Value:
2021-0039-0020-0000
Page Start:
2317
Page End:
2318
Publication Date:
2021-07-10
Subjects:
Oncology -- Periodicals
Cancer -- Periodicals
Oncology
Medical Oncology
Cancérologie -- Périodiques
Cancer -- Périodiques
Cancérologie
Cancer
Oncology
Oncologia
Càncer
Periodicals
616.994
Journal URLs:
http://www.jco.org/ ↗
http://jco.ascopubs.org/ ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:
10.1200/JCO.20.03262 ↗
Languages:
English
ISSNs:
0732-183X
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
21454.xml